Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study.
Journal article
Chan K. et al, (2024), Lancet, 403, 2606 - 2618
Using artificial intelligence to study atherosclerosis, predict risk and guide treatments in clinical practice.
Journal article
Antoniades C. et al, (2023), Eur Heart J, 44, 437 - 439
Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease N.
Journal article
Polkinghorne MD. et al, (2023), EUROPEAN HEART JOURNAL, 44
THE ROLE OF CTA RADIOTRANSCRIPTOMIC PHENOTYPING IN UNDERSTANDING THE VASCULAR EFFECTS OF LP(A) IN ADVANCED ATHEROSCLEROSIS
Conference paper
Xie C. et al, (2023), HEART, 109, A270 - A271